Abstract
Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.
| Original language | English |
|---|---|
| Pages (from-to) | 181-192 |
| Number of pages | 12 |
| Journal | Maturitas |
| Volume | 54 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - May 20 2006 |
Fingerprint
Keywords
- Hormone replacement therapy
- Personal use
- Survey
- Women doctors
ASJC Scopus subject areas
- Ageing
- Obstetrics and Gynaecology
Cite this
Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial. / Biglia, Nicoletta; Ujcic, Ester; Kubatzki, Franziska; Sgandurra, Paola; Robba, Claudio; Ponzone, Riccardo; Sismondi, Piero.
In: Maturitas, Vol. 54, No. 2, 20.05.2006, p. 181-192.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial
AU - Biglia, Nicoletta
AU - Ujcic, Ester
AU - Kubatzki, Franziska
AU - Sgandurra, Paola
AU - Robba, Claudio
AU - Ponzone, Riccardo
AU - Sismondi, Piero
PY - 2006/5/20
Y1 - 2006/5/20
N2 - Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.
AB - Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.
KW - Hormone replacement therapy
KW - Personal use
KW - Survey
KW - Women doctors
UR - http://www.scopus.com/inward/record.url?scp=33748062352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748062352&partnerID=8YFLogxK
U2 - 10.1016/j.maturitas.2005.10.008
DO - 10.1016/j.maturitas.2005.10.008
M3 - Article
C2 - 16330170
AN - SCOPUS:33748062352
VL - 54
SP - 181
EP - 192
JO - Maturitas
JF - Maturitas
SN - 0378-5122
IS - 2
ER -